Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

OIG Cardiac Implant Review Finds $1.5bn In Medicare Payments For Failed, Recalled Devices

Executive Summary

Medicare was billed $1.5bn, and beneficiaries paid $140 million in copayments, for procedures associated with replacing seven models of defective or failed cardiac implants, according to preliminary results from an ongoing review by the US Department of Health and Human Services’ Office of Inspector General. The "early alert" from OIG’s investigation blamed a lack of device identifiers on claims forms for masking device performance data.


Related Content

Recalled Device Costs, Test Payments Focus In OIG Work Plan
Medicare Agency Comes On Board With Adding UDIs To Claims Forms





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst